Baylor Genetics ยท 10 hours ago
Director, Corporate Financial Planning & Analysis
Baylor Genetics is seeking a Director, Corporate Financial Planning & Analysis to lead the strategic financial planning, budgeting, and forecasting processes. This role is crucial in aligning financial strategy with long-term business goals and involves providing executive-level insights to leadership and stakeholders.
BiotechnologyHealth Care
Responsibilities
Lead the development of company-wide financial models and long-term forecasts
Translate strategic objectives into detailed financial plans aligned with organizational priorities
Collaborate with executive leadership to assess financial performance, risks, and growth opportunities
Oversee the annual budgeting process and rolling forecasts
Ensure alignment between actual results and forecasts, identifying key trends and drivers
Partner with department heads to develop financially sound operational plans
Lead revenue and margin analysis to support strategic decision-making
Drive business performance by analyzing sales trends, pricing strategies, and market dynamics
Provide financial insights that support resource allocation and investment decisions
Develop and maintain dashboards, planning and reporting tools for executive and departmental use including Adaptive planning platform
Provide timely and actionable financial insights to guide company performance
Build and lead a high-performing FP&A team
Foster a culture of collaboration, continuous improvement, and accountability
Qualification
Required
Bachelor's degree in Finance, Accounting, or a related field
Minimum of 10 years of experience in financial planning and analysis or corporate finance
At least 3 years in a financial leadership role
Proven success in FP&A process improvement
Experience in Adaptive planning platform implementation required
Strong background in financial modeling, budgeting, and strategic forecasting
Preferred
MBA or relevant advanced degree
Company
Baylor Genetics
Baylor Genetics offers a full spectrum of cost-effective, genetic testing, and provides clinically relevant solutions.
Funding
Current Stage
Late StageRecent News
Company data provided by crunchbase